| Crinipan® PMC green | Symrise |
|
Crinipan® PMC green is the first micro-activated natural-derived anti-dandruff active with equivalent activity to the established benchmark climbazole. The new molecule combines effectiveness and a smart mode of action: activated on scalp by Malassezia en...veja mais
Crinipan® PMC green is the first micro-activated natural-derived anti-dandruff active with equivalent activity to the established benchmark climbazole. The new molecule combines effectiveness and a smart mode of action: activated on scalp by Malassezia enzymes, its activity is being directly triggered by the dandruff causing microorganism itself. In 2020 Crinipan® PMC green has received both, the BSB Innovation Award - 1st place in the category 'Ingredients/Actives', and the SEPAWA innovation award. In 2022 Crinipan® PMC green has received the BSB Environmental Award - 1st place in the category ‘raw materials’. veja menos
Informações sobre conformidade disponíveis
|
|
| dermosoft® decalact MB | Evonik – Personal Care |
|
dermosoft® decalact MB is a natural, multifunctional active ingredient with antimicrobial properties. It is highly effective against microorganisms causing skin disorders like dandruff and athlete's foot. Therefore, this material can be applied as a natur...veja mais
dermosoft® decalact MB is a natural, multifunctional active ingredient with antimicrobial properties. It is highly effective against microorganisms causing skin disorders like dandruff and athlete's foot. Therefore, this material can be applied as a natural and mild replacement for triclosan and climbazole. This material is supplied by Evonik Dr. Straetmans GmbH, a subsidiary of Evonik. Dr. Straetmans is a trademark of Evonik Operations GmbH. veja menos
Informações sobre conformidade disponíveis
|
Request Sample |
| TEQPON CLL | Kale Care Chemicals |
|
TEQPON CLL is a water-free and PEG-free anionic surfactant with excellent foaming power. It improves the foam properties in height and quality. It also efficient against dandruff on the scalp. Usage rate is %2,0.
Informações sobre conformidade disponíveis
|
